Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PTC Therapeutics Inc (NASDAQ:PTCT)

Delayed Data
As of Nov 24
 +0.94 / +3.05%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 84.50, with a high estimate of 135.00 and a low estimate of 26.00. The median estimate represents a +166.14% increase from the last price of 31.75.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in PTC Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.05%
Growthannually -62.36%


Growthquarterly 35.36%
Growthannually 47.04%
Key to the earnings and sales forecast charts.